Login
Super Investors Blue Owl Capital Holdings LP
BO

Blue Owl Capital Holdings LP

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$548M
Positions
79
Quarter ended
September 30, 2026
Filed
November 13, 2026

Reported portfolio value by quarter (20 quarters reported)

$665M $129M
Q4 21 Q4 22 Q4 23 Q4 24 Q4 25 Q3 26

$301M in Q4 2021 → $548M now. Hover for any quarter.

Holdings

As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
SE Space Exploration Techn Corp 25.4% Trimmed 34% 923,218 $139M
Aktis Oncology Inc 11.9% Added 8.9% 3,343,827 $65.1M
LB Latigo Biotherapeutics Inc 11.0% New 3,596,780 $60.1M
Larimar Therapeutics Inc 5.8% Added 8.3% 9,923,904 $31.7M
ET Electra Therapeutics Inc 5.4% New 2,611,143 $29.4M
NC Nuveen Churchill Direct Lend 4.4% Unchanged 2,143,626 $24.1M
Cullinan Therapeutics Inc 3.9% Trimmed 9.1% 1,399,899 $21.5M
Blue Owl Capital Corporation 3.9% Unchanged 2,045,070 $21.5M
Obsidian Therapeutics Inc 3.7% New 1,482,767 $20.4M
Sagimet Biosciences Inc 2.0% Trimmed 11% 1,125,544 $11.1M
Dell Technologies Inc 1.9% Trimmed 41% 19,342 $10.4M
Holley Inc 1.9% Unchanged 4,376,888 $10.3M
Conduent Inc 1.4% Unchanged 5,036,595 $7.86M
DF Deep Fission Inc 1.2% Unchanged 1,333,333 $6.84M
Aquestive Therapeutics Inc 1.2% Added 47% 1,390,632 $6.44M
Immix Biopharma Inc 1.1% Added 38% 602,047 $6.26M
Maplight Therapeutics Inc 1.0% Trimmed 24% 556,371 $5.67M
Veradermics Inc 1.0% New 45,000 $5.46M
Imagenebio Inc 0.9% Added 24% 1,135,081 $5.2M
Opus Genetics Inc 0.9% New 969,605 $4.69M
Corvus Pharmaceuticals Inc 0.8% Trimmed 41% 358,600 $4.13M
Rezolute Inc 0.7% New 935,000 $3.87M
Artiva Biotherapeutics Inc 0.7% Trimmed 39% 529,542 $3.77M
Cybin Inc 0.6% Added 381% 288,282 $3.54M
AL Achieve Life Science Inc 0.6% New 412,654 $3.34M
Procore Technologies Inc 0.6% New 64,030 $3.31M
Compass Therapeutics Inc 0.6% Trimmed 13% 3,154,076 $3.28M
PT Palvella Therapeutics Inc Ne 0.6% Trimmed 37% 23,003 $3.17M
Zura Bio Ltd 0.6% New 735,000 $3.06M
Lenz Therapeutics Inc 0.5% Added 3.3% 781,722 $3M
SP Starwood Ppty Tr Inc 0.5% Unchanged 196,355 $2.65M
PO Pyxis Oncology Inc 0.4% New 1,000,000 $2.33M
VT Viridian Therapeutics Inc 0.4% Trimmed 62% 100,000 $2.06M
Netskope Inc 0.3% New 97,148 $1.69M
Servicetitan Inc 0.3% New 25,360 $1.67M
First Advantage Corp 0.3% New 88,665 $1.58M
Eledon Pharmaceuticals Inc 0.3% Unchanged 566,509 $1.43M
WI Ww Intl Inc 0.2% Trimmed 16% 71,277 $1.1M
Adc Therapeutics Sa 0.2% Unchanged 733,568 $895K
Compass Pathways PLC Call 0.2% Trimmed 52% 800,000 $888K
Stablecoinx Inc 0.2% Trimmed 33% 167,795 $839K
Marker Therapeutics Inc 0.1% Unchanged 554,250 $593K
FH Fold Hldgs Inc 0.1% Unchanged 856,632 $454K
ND Niocorp Devs Ltd 0.0% Unchanged 268,280 $201K
Sagimet Biosciences Inc Call 0.0% New 365,400 $201K
Viking Therapeutics Inc Call 0.0% New 300,000 $181K
Piper Sandler Companies 0.0% Unchanged 2,428 $160K
Caris Life Sciences Inc 0.0% Unchanged 4,711 $144K
Rezolve Ai PLC 0.0% Unchanged 235,121 $129K
ET Energy Transfer L P 0.0% Unchanged 5,326 $105K
Engene Therapeutics Inc 0.0% Unchanged 511,177 $102K
Eledon Pharmaceuticals Inc Call 0.0% Unchanged 200,000 $100K
VG Vodafone Group PLC 0.0% Unchanged 5,371 $86.8K
Compass Therapeutics Inc Call 0.0% Added 104% 619,700 $48.8K
Brand Engagement Network Inc 0.0% Trimmed 49% 746,953 $37.3K
AM Alpha Modus Hldgs Inc 0.0% Unchanged 1,854,665 $37.1K
TR Tactical Res Corp 0.0% New 11,250 $29.9K
Monte Rosa Therapeutics Inc 0.0% New 2,392 $28.5K
Dave Inc 0.0% Unchanged 28,750 $28.2K
Roadzen Inc 0.0% Unchanged 225,000 $22.5K

Showing top 60 of 79 positions.

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

Q3 2026

quarter ended September 30, 2026 · filed November 13, 2026

Company Action Shares changed Value of change % of portfolio
SE Space Exploration Techn Corp Trimmed −475,597 −$71.7M 25.4%
LB Latigo Biotherapeutics Inc New +3,596,780 +$60.1M 11.0%
ET Electra Therapeutics Inc New +2,611,143 +$29.4M 5.4%
CO Capital One Finl Corp Exited −119,757 −$24M —
Obsidian Therapeutics Inc New +1,482,767 +$20.4M 3.7%
Eyepoint Inc Exited −762,594 −$10.9M —
Dell Technologies Inc Trimmed −13,619 −$7.33M 1.9%
Rhythm Pharmaceuticals Inc Exited −61,455 −$6.82M —
Compass Pathways PLC Exited −450,000 −$6.37M —
UP Ultragenyx Pharmaceutical In Exited −182,638 −$6.1M —

Showing the 10 largest of 55 changes.

Q2 2026

quarter ended June 30, 2026 · filed August 11, 2026

Company Action Shares changed Value of change % of portfolio
SE Space Exploration Techn Corp New +1,398,815 +$239M 36.0%
Engene Holdings Inc Exited −4,416,353 −$30.1M —
CO Capital One Finl Corp New +119,757 +$24M 3.6%
DF Deep Fission Inc New +1,333,333 +$14.7M 2.2%
Maplight Therapeutics Inc Trimmed −276,000 −$9.89M 3.9%
Artiva Biotherapeutics Inc New +874,542 +$8.48M 1.3%
Dell Technologies Inc Added +19,062 +$8.22M 2.1%
Sagimet Biosciences Inc Added +926,667 +$7.16M 1.5%
Cullinan Therapeutics Inc Trimmed −370,000 −$6.74M 4.2%
Compass Pathways PLC New +450,000 +$6.37M 1.0%

Showing the 10 largest of 69 changes.

Q1 2026

quarter ended March 31, 2026 · filed May 14, 2026

Company Action Shares changed Value of change % of portfolio
Aktis Oncology Inc New +3,161,348 +$56.6M 15.2%
Maplight Therapeutics Inc Added +678,871 +$13.8M 5.5%
Repare Therapeutics Inc Exited −3,443,659 −$8.95M —
Corvus Pharmaceuticals Inc New +545,000 +$7.97M 2.1%
Engene Holdings Inc Added +1,055,416 +$7.19M 8.1%
Procore Technologies Inc Exited −94,264 −$6.86M —
Eyepoint Inc Added +520,000 +$6.7M 3.2%
Dell Technologies Inc Trimmed −39,949 −$6.56M 0.6%
Cullinan Therapeutics Inc Trimmed −441,208 −$6.27M 7.3%
Context Therapeutics Inc Trimmed −2,343,891 −$6.14M 3.6%

Showing the 10 largest of 73 changes.

Q4 2025

quarter ended December 31, 2025 · filed February 20, 2026

Company Action Shares changed Value of change % of portfolio
Evercommerce Inc Exited −1,641,929 −$18.3M —
Roivant Sciences Ltd Trimmed −725,000 −$15.7M 1.8%
NC Nuveen Churchill Direct Lend Trimmed −947,927 −$12.6M 8.8%
Procore Technologies Inc New +94,264 +$6.86M 2.1%
Disc Medicine Inc Exited −102,260 −$6.76M —
PT Palvella Therapeutics Inc Ne Trimmed −55,000 −$5.76M 1.3%
Maplight Therapeutics Inc New +327,058 +$5.74M 1.8%
Immix Biopharma Inc New +986,240 +$5.16M 1.6%
Korro Bio Inc Exited −105,000 −$5.03M —
UP Ultragenyx Pharmaceutical In Trimmed −209,800 −$4.83M 1.5%

Showing the 10 largest of 56 changes.

Q3 2025

quarter ended September 30, 2025 · filed November 12, 2025

Company Action Shares changed Value of change % of portfolio
Tourmaline Bio Inc Exited −997,107 −$15.9M —
Roivant Sciences Ltd New +988,249 +$15M 4.6%
NC Nuveen Churchill Direct Lend Trimmed −948,000 −$13.1M 13.2%
Mineralys Therapeutics Inc Trimmed −235,000 −$8.91M 1.2%
Tango Therapeutics Inc Trimmed −695,000 −$5.84M 0.3%
Ikena Oncology Inc Exited −4,091,118 −$5.48M —
Tempus Ai Inc Exited −80,167 −$5.09M —
UP Ultragenyx Pharmaceutical In Added +167,200 +$5.03M 3.9%
Dell Technologies Inc Added +31,486 +$4.46M 2.3%
Imagenebio Inc New +540,924 +$4.41M 1.4%

Showing the 10 largest of 37 changes.

Q2 2025

quarter ended June 30, 2025 · filed August 11, 2025

Company Action Shares changed Value of change % of portfolio
PT Proshares Tr Exited −175,000 −$10M —
Tango Therapeutics Inc Trimmed −1,307,236 −$6.69M 1.3%
Tempus Ai Inc New +80,167 +$5.09M 1.6%
UP Ultragenyx Pharmaceutical In Added +102,000 +$3.71M 3.0%
E2open Parent Holdings Inc Exited −1,650,943 −$3.3M —
Conduent Inc Trimmed −1,240,602 −$3.28M 3.8%
Keros Therapeutics Inc Exited −266,033 −$2.71M —
SP Starwood Ppty Tr Inc New +131,461 +$2.64M 0.9%
Dell Technologies Inc New +20,848 +$2.56M 0.8%
Compass Pathways PLC Trimmed −905,914 −$2.54M 0.2%

Showing the 10 largest of 47 changes.

Q1 2025

quarter ended March 31, 2025 · filed May 15, 2025

Company Action Shares changed Value of change % of portfolio
Klaviyo Inc Exited −1,078,770 −$44.5M —
PT Proshares Tr New +175,000 +$10M 3.2%
Acelyrin Inc Exited −2,783,946 −$8.74M —
Civeo Corp New +348,226 +$8.01M 2.6%
Holley Inc Added +2,327,746 +$5.98M 4.4%
Mineralys Therapeutics Inc New +206,296 +$3.28M 1.1%
Palvella Therapeutics Inc Trimmed −109,803 −$3.07M 1.3%
Compass Pathways PLC Added +974,590 +$2.79M 1.0%
Nextnav Inc New +198,760 +$2.42M 0.8%
Mereo Biopharma Group PLC Exited −672,809 −$2.35M —

Showing the 10 largest of 49 changes.

Q4 2024

quarter ended December 31, 2024 · filed February 14, 2025

Company Action Shares changed Value of change % of portfolio
PT Proshares Tr Exited −325,000 −$23.6M —
Tourmaline Bio Inc Trimmed −451,080 −$9.15M 5.0%
Conduent Inc Added +2,262,437 +$9.14M 5.2%
Eledon Pharmaceuticals Inc New +1,959,912 +$8.07M 1.9%
Lanzatech Global Inc Exited −2,926,514 −$5.59M —
Tango Therapeutics Inc New +1,732,152 +$5.35M 1.2%
CI Ccc Intelligent Solutions Hl Exited −457,104 −$5.05M —
Eyepoint Pharmaceuticals Inc New +667,594 +$4.97M 1.1%
Klaviyo Inc Trimmed −119,500 −$4.93M 10.3%
Starwood Property Trust Exited −226,456 −$4.62M —

Showing the 10 largest of 106 changes.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support